PMID- 14643272 OWN - NLM STAT- MEDLINE DCOM- 20040210 LR - 20190513 IS - 0195-668X (Print) IS - 0195-668X (Linking) VI - 24 IP - 23 DP - 2003 Dec TI - The angiotensin converting enzyme inhibitor trandolapril has neutral effect on exercise tolerance or functional class in patients with myocardial infarction and reduced left ventricular systolic function. PG - 2116-22 AB - AIMS: To study the effect of angiotensin-converting enzyme (ACE) inhibitor trandolapril on exercise tolerance time (ETT) and New York Heart Association (NYHA) classification in patients with reduced left ventricular systolic dysfunction (LVSD) after acute myocardial infarction (AMI). METHODS AND RESULTS: The TRAndolapril Cardiac Evaluation (TRACE) was a randomized controlled study designed to evaluate the effect of trandolapril on mortality in 1749 consecutive Danish patients with LVSD after AMI. NYHA class was recorded every 3 months in all patients. In a prospective sub-study, 254 patients underwent exercise tolerance tests at 1, 3 and 12 months. The two treatment arms showed equal improvement in NYHA class both in the entire and exclusively symptomatic population over 4 years of follow-up (P=ns). ETT increased equally in both treatment arms at 1, 3, 12 months (P=ns). A mean of 12mg/day of furosemide was spared in trandolapril arm (P=0.001). CONCLUSIONS: Trandolapril had a mild diuretic-sparing effect. These results emphasis the importance of explaining to patients that ACE inhibitors provide protection against death and hospitalisation for heart failure but do not have any significant effect upon symptoms. FAU - Abdulla, Jawdat AU - Abdulla J AD - Department of Cardiology, Gentofte University Hospital, Copenhagen, Denmark. jawab@dadlnet.dk FAU - Burchardt, Hans AU - Burchardt H FAU - Z Abildstrom, Steen AU - Z Abildstrom S FAU - Kober, Lars AU - Kober L FAU - Torp-Pedersen, Christian AU - Torp-Pedersen C CN - TRACE Study Group LA - eng PT - Clinical Trial PT - Journal Article PT - Multicenter Study PT - Randomized Controlled Trial PT - Research Support, Non-U.S. Gov't PL - England TA - Eur Heart J JT - European heart journal JID - 8006263 RN - 0 (Angiotensin-Converting Enzyme Inhibitors) RN - 0 (Indoles) RN - 1T0N3G9CRC (trandolapril) SB - IM CIN - Eur Heart J. 2004 Mar;25(5):447-8; author reply 448. PMID: 15033260 MH - Aged MH - Angiotensin-Converting Enzyme Inhibitors/*therapeutic use MH - Drug Evaluation MH - Exercise Test MH - Exercise Tolerance/drug effects MH - Female MH - Follow-Up Studies MH - Humans MH - Indoles/*therapeutic use MH - Male MH - Myocardial Infarction/*drug therapy/physiopathology MH - Prospective Studies MH - Survival Analysis MH - Treatment Outcome MH - Ventricular Dysfunction, Left/*drug therapy/physiopathology EDAT- 2003/12/04 05:00 MHDA- 2004/02/11 05:00 CRDT- 2003/12/04 05:00 PHST- 2003/12/04 05:00 [pubmed] PHST- 2004/02/11 05:00 [medline] PHST- 2003/12/04 05:00 [entrez] AID - S0195668X03005761 [pii] AID - 10.1016/j.ehj.2003.09.004 [doi] PST - ppublish SO - Eur Heart J. 2003 Dec;24(23):2116-22. doi: 10.1016/j.ehj.2003.09.004.